Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks
- 31 May 1997
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 36 (5), 789-792
- https://doi.org/10.1016/s0190-9622(97)80351-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- TINEA PEDIS (MOCASSINTYPE) TREATED WITH ITRACONAZOLEInternational Journal of Dermatology, 1995
- Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea crurisJournal of the American Academy of Dermatology, 1994
- Antifungal agents: An overview. Part IIJournal of the American Academy of Dermatology, 1994
- Clinical Experience with Short Schedules of Itraconazole in the Treatment of Tinea corporis and/or Tinea crurisDermatology, 1994
- Itraconazole in the treatment of tinea corporis and tinea crurisClinical and Experimental Dermatology, 1993
- Itraconazole in common dermatophyte infections of the skin: Fixed treatment schedulesJournal of the American Academy of Dermatology, 1990
- Double‐Blind Comparison of Itraconazole with Griseofulvin in the Treatment of Tinea Pedis and Tinea Manuum./Doppelblind‐Vergleich von Itraconazol mit Griseofulvin bei der Behandlung von Tinea pedis und Tinea manuumMycoses, 1988
- Pharmacokinetic profile of orally administered itraconazole in human skinJournal of the American Academy of Dermatology, 1988
- Treatment of Chronic Dermatophytosis and Chronic Oral Candidosis with ItraconazoleClinical Infectious Diseases, 1987
- Oral ketoconazole. An effective and safe treatment for dermatophytosisArchives of Dermatology, 1981